Dumont & Blake Investment Advisors LLC Purchases New Position in CME Group Inc. (NASDAQ:CME)

Dumont & Blake Investment Advisors LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 870 shares of the financial services provider’s stock, valued at approximately $202,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. Truvestments Capital LLC acquired a new stake in CME Group in the 3rd quarter worth about $26,000. SJS Investment Consulting Inc. increased its holdings in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC raised its position in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares in the last quarter. Fortitude Family Office LLC boosted its stake in shares of CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its position in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Piper Sandler raised their target price on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Barclays boosted their target price on shares of CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research report on Monday, December 9th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Monday, January 6th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average target price of $229.27.

CME Group Trading Up 1.5 %

NASDAQ CME opened at $235.92 on Friday. The company has a market cap of $85.02 billion, a price-to-earnings ratio of 24.81, a price-to-earnings-growth ratio of 5.28 and a beta of 0.56. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $249.02. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The business’s fifty day moving average is $234.40 and its 200 day moving average is $222.08.

CME Group Increases Dividend

The company also recently declared a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were paid a dividend of $5.80 per share. This is a positive change from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group announced that its Board of Directors has approved a stock buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Insider Transactions at CME Group

In other CME Group news, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.